Part 3/7:
The process of securing sufficient vaccine doses has been fraught with difficulties. Negotiations with pharmaceutical companies proved complicated, with limited manufacturers willing to supply doses to developing countries like Indonesia and the Philippines. Developed countries often prioritized their populations or alliances, creating a competitive and limited market for vaccines.
This vaccine scarcity has led to a bottleneck effect, especially in regions that rely heavily on imports. Limited production capacity and prioritization strategies have resulted in delays and reduced access, exacerbating the disparity between countries.